| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |